Evaluation of MetriGenix custom 4D arrays applied for detection of breast cancer subtypes.

ABSTRACT:

Background

Previously, a total of five breast cancer subtypes have been identified based on variation in gene expression patterns. These expression profiles were also shown to be associated with different prognostic value. In this study tumour samples from 27 breast cancer patients, previously subtyped by expression analysis using DNA microarrays, and four controls from normal breast tissue were included. A new MetriGenix 4D array proposed for diagnostic use was evaluated.

Methods

We applied MetriGenix custom 4D arrays for the detection of previously defined molecular subtypes of breast cancer. MetriGenix 4D arrays have special features including probe immobilization in microchannels with chemiluminescence detection that enable shorter hybridization time.

Results

The

SUBMITTER: Muggerud AA 

PROVIDER: S-EPMC1421426 | biostudies-literature | 2006 Mar

REPOSITORIES: biostudies-literature